Re: CS>Bill to Boost Industry Fees That Fund FDA-Even more off topic
On Saturday, May 25, 2002, at 03:10 AM, Ed Kasper wrote: Ed Kasper L.Ac., Acupuncturist & Medicinal Herbalist http://HappyHerbalist.com kombu...@happyherbalist.com This whole Happy this or that thing got it's start with the book the Happy Hooker by Xaveria Hollander. She was my email buddy a few years back when she was first dipping her toes in the internet waters. I'm sure you will all be happy to know she is alive, doing well, a bit over weight but having lots of fun with young men. Bless her heart. -- The silver-list is a moderated forum for discussion of colloidal silver. To join or quit silver-list or silver-digest send an e-mail message to: silver-list-requ...@eskimo.com -or- silver-digest-requ...@eskimo.com with the word subscribe or unsubscribe in the SUBJECT line. To post, address your message to: silver-list@eskimo.com Silver-list archive: http://escribe.com/health/thesilverlist/index.html List maintainer: Mike Devour
RE: CS>Bill to Boost Industry Fees That Fund FDA
My thinking on that is that only with huge fees and much red tape can the industry keep out the competition Ed Kasper L.Ac., Acupuncturist & Medicinal Herbalist http://HappyHerbalist.com kombu...@happyherbalist.com -Original Message- From: Gary Green [mailto:lim...@pc.jaring.my] Sent: Friday, May 24, 2002 6:19 AM To: silver-list@eskimo.com Subject: Re: CS>Bill to Boost Industry Fees That Fund FDA On Friday, May 24, 2002, at 08:56 PM, Connie wrote: With little public discussion and limited debate on Capitol Hill, Congress is moving to substantially expand the program through which companies pay large fees to the Food and Drug Administration to review their new drug applications -- making the agency increasingly dependent on the businesses that it regulates. END QUOTE Just business as usual from the people that gave you the Lone-Nut theory and the Magic-Bullet.
Re: CS>Bill to Boost Industry Fees That Fund FDA
On Friday, May 24, 2002, at 08:56 PM, Connie wrote: With little public discussion and limited debate on Capitol Hill, Congress is moving to substantially expand the program through which companies pay large fees to the Food and Drug Administration to review their new drug applications -- making the agency increasingly dependent on the businesses that it regulates. END QUOTE Just business as usual from the people that gave you the Lone-Nut theory and the Magic-Bullet.
